The Advanced Technology Pavilion treated its first essential tremor patient with an MR-Guided Focused Ultrasound, a non-surgical approach to ablating the thalamus in the brain, with Dr. Christopher Duma.

The Advanced Technology Pavilion reduced resources and waste by eliminating the Malignant Hyperthermia cart and streamlining its pharmacy workflow.

The Advanced Technology Pavilion offered the thoracentesis procedure in its location, so patients do not need to go to the hospital.

The Interventional Radiology team began to treat patients with Histotripsy, a non-surgical and non-radiation approach to treating liver cancer.

The Hoag Hospital Newport Beach Blood Bank was found to have zero deficiencies during the U.S. Food & Drug Administration’s unannounced biennial inspection.

The addition of Pharmacy Technicians Emergency Departments at HHNB and HHI has resulted in 100 percent of ED-admitted patients having their home medication lists documented in Epic within 24 hours of admission, a 66 percent increase over 2023.

The laboratory reduced the order-to-issue of blood products in a Code RBC from eight minutes to three minutes. Process improvements include first wave issued manually and containing uncrossmatched RBC and pre-thawed plasma.

All laboratory leads, supervisors, managers and its director completed all modules of a lab leadership development strategy designed to supplement and build leadership acumen and standardize philosophy and culture.

In collaboration with the Hoag Family Cancer Institute, the lab prioritized interfacing with pathology molecular reference labs to allow for results that support diagnosis and treatment to directly post into Epic.

The lab launched in-house molecular TB testing, in collaboration with the infection prevention team. This allows for faster access to appropriate treatment, which improves patient outcomes, reduces airborne isolation duration and decreases test turnaround time from days to hours.